Combination of aripiprazole and valproate in children with tic disorders: Case series
Article Sidebar
Main Article Content
Abstract
Tics are characterised by involuntary, repetitive movements and vocalisations that significantly impair affected children’s quality of life. These disorders, primarily originating in the basal ganglia, are often misdiagnosed and inadequately treated. The exact aetiology of tic disorders is believed to involve a combination of genetic, neurobiological and environmental factors. Stress is an exacerbating factor leading to an increase in tic frequency and intensity.
We present three cases of children diagnosed with tic disorders and who exhibited substantial improvement through a combination of aripiprazole and valproate. The children, aged 7 to 15 years, had previously received various treatments with limited success. Upon switching to the combined therapy of with aripiprazole and valproate, they showed marked improvement in tic severity and associated behavioural issues. The combination treatment requires further research to validate our observations and to refine treatment protocols for children with tic disorders.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. Ueda K, Black KJ. A comprehensive review of tic disorders in children. J Clin Med 2021;10(11):2479. https://doi.org/10.3390/jcm10112479
2. Eapen V, Usherwood T. Assessing tics in children. BMJ 2022;376(8329):e069346.
https://doi.org/10.1136/bmj-2021-069346
3. Greydanus DE, Tullio J. Tourette’s disorder in children and adolescents. Transl Pediatr 2020;9(S1):S94-S103. https://doi.org/10.21037/tp.2019.09.11
4. Essoe JK-Y, Grados MA, Singer HS, Myers NS, McGuire JF. Evidence- based treatment of Tourette’s disorder and chronic tic disorders. Expert Rev Neurother 2019;19(11):1103-1115. https://doi.org/10.1080/14737175.2019.16 43236
5. Roessner V, Eichele H, Stern JS, et al. European clinical guidelines for Tourette syndrome and other tic disorders – version 2.0. Part III: Pharmacological treatment. Eur Child Adolesc Psychiatry 2022;31(3):425-441. https://doi. org/10.1007/s00787-021-01899-z
6. Billnitzer A, Jankovic J. Current Management of tics and Tourette syndrome: Behavioral, pharmacologic, and surgical treatments. Neurotherapeutics 2020;17(4):1681-1693. https://doi.org/10.1007/s13311-020-00914-6
7. Ramteke A, Lamture Y. Tics and Tourette syndrome: A literature review of etiological, clinical, and pathophysiological aspects. Cureus 2022;14(8): e28575. https://doi.org/10.7759/cureus.285758. Tao D, Zhong T, Ma S, Li J, Li X. Randomised controlled clinical trial comparing the efficacy and tolerability of aripiprazole and sodium valproate in the treatment of Tourette syndrome. Ann Gen Psychiatry 2019;18(1):24. https://doi.org/10.1186/s12991-019-0245-3
9. Sarıgedik E, Kara N, Yektas C. Asymmetric tremor due to possible valproic acid-aripiprazole interaction in a child with severe intellectual disability (eng). J Clin Psychiatry 2021;24(1):123-126. https://doi.org/10.5505/kpd.2020.32549
10. Yang C-S, Zhang L-L, Lin Y-Z, Guo Q. Sodium valproate for the treatment of Tourette’s syndrome in children: A systematic review and meta- analysis. Psychiatry Res 2015;226(2-3):411-417. https://doi.org/10.1016/j. psychres.2014.08.058